These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 493376)

  • 1. Prescription drug coverage: insurance or prepayment?
    Rucker TD
    Pharm Manage Comb Am J Pharm; 1979; 151(4):171-3. PubMed ID: 493376
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 4. What's at stake.
    Gordon JR; Maule CJ
    CPJ; 1989 Feb; 122(2):74-6, 78. PubMed ID: 10292087
    [No Abstract]   [Full Text] [Related]  

  • 5. Third-party reimbursement: new concepts and contemporary issues.
    Paul SH; McEvilla JD
    Med Mark Media; 1980 Oct; 15(10):58-61, 64-70. PubMed ID: 10249123
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare prescription drug coverage (part D): challenges and opportunities.
    Witten B
    Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
    [No Abstract]   [Full Text] [Related]  

  • 7. An analysis of capitation rates for prescription medication benefits from an insurance perspective.
    Lawson KA
    Benefits Q; 1991; 7(3):52-61. PubMed ID: 10117172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fee for the service of pharmacy: the time has come.
    Tanner DJ
    Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821
    [No Abstract]   [Full Text] [Related]  

  • 9. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential impact of prepayment on Medicaid drug costs.
    Yesalls CE; Norwood GJ; Lipson DP
    Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462
    [No Abstract]   [Full Text] [Related]  

  • 11. 24th annual prescription survey, Albany College of Pharmacy.
    DeNuzzo RV
    Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for managing prescription drug costs.
    Stern L
    Bus Health; 1990 Jun; 8(6):41-2, 44. PubMed ID: 10104793
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
    Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
    Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare and the politics of prescription drug pricing.
    Oberlander J
    N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
    [No Abstract]   [Full Text] [Related]  

  • 16. The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder.
    Harpe SE; Szeinbach SL; Caswell RJ; Corey R; McAuley JW
    J Urol; 2007 Dec; 178(6):2532-6; discussion 2536. PubMed ID: 17937937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rx fee in Utah rises if drug quantity extends beyond 30 days.
    Pharm Times; 1983 Sep; 49(9):32-3. PubMed ID: 10262970
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.
    Gupta K; Cline RR; Schondelmeyer SW
    Res Social Adm Pharm; 2006 Jun; 2(2):232-53. PubMed ID: 17138510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 20. Making medicines affordable. A number of states have for years helped older Americans buy needed prescription drugs.
    Cauchi R
    State Legis; 1999 Dec; 25(10):10-1. PubMed ID: 10848098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.